TEMOZAD 20MG

Temozad 20mg Capsule contains the active component temozolomide. This medication is classified as an Antitumor agent. It is utilized for the treatment of brain cancer, specifically glioblastoma multiforme in adults and malignant glioma, which includes glioblastoma multiforme or anaplastic astrocytoma in patients over the age of three. Glioblastoma and anaplastic astrocytoma are recognized as the most prevalent and aggressive forms of brain cancer, associated with low survival rates. Anaplastic astrocytoma is managed with Temozad 20mg Capsule or radiotherapy following a biopsy, while Glioblastoma multiforme is treated using a combination of radiotherapy and Temozad 20mg Capsule, which is then continued as maintenance therapy.

The typical side effects that may occur with Temozad 20mg Capsule include nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, fatigue, frequent urination, vision and hearing issues, elevated blood sugar levels, muscle damage, pain in muscles and joints, memory impairment, coordination difficulties, infections, sleep disturbances, and weight loss. It is important to inform your doctor if any of these symptoms are bothersome or persist.

Notify your physician if you have an allergy to Temozad 20mg Capsule or any of its components. Prior to commencing treatment with this medication, inform your physician if you have a hepatitis B infection, anemia, low platelet count, reduced levels of RBC and WBC, blood clotting disorders, or any liver or kidney issues. Your physician will regularly monitor your WBC and platelet counts. It is advised to avoid this medication if you are pregnant or breastfeeding. Both women and men should employ birth control methods to prevent pregnancy and fathering a child.